Evidence map›Paper›PMID 34950038›Full record

ArticleFrontiers in pharmacology2021

Proteomics Analysis of Tears and Saliva From Sjogren's Syndrome Patients.

Nabangshu Das, Nikhil G Menon, Luiz G N de Almeida, Paige S Woods, Miriam L Heynen, Gregory D Jay, Barbara Caffery, Lyndon Jones, Roman Krawetz, Tannin A Schmidt and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. FASN-mediated metabolic reprogramming drives CD4Arthritis research & therapy · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Alveolar macrophage function is impaired following inhalation of berry e-cigarette vapor.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Integrating the analysis of human biopsies using post-translational modifications proteomics.Protein science : a publication of the Protein Society · 2024
    Review
  15. Unraveling the Intraday Variations in the Tear Fluid Proteome.Investigative ophthalmology & visual science · 2024
    Article
  16. Liquid Biopsy Proteomics in Ophthalmology.Journal of proteome research · 2024
    Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Nabangshu DasDepartments of Physiology and Pharmacology and Kinesiology, University of Calgary, Calgary, AB, Canada.
Nikhil G MenonDepartment of Biomedical Engineering, School of Dental Medicine, UConn Health, Farmington, CT, United States.
Luiz G N de AlmeidaDepartments of Physiology and Pharmacology and Kinesiology, University of Calgary, Calgary, AB, Canada.
Paige S WoodsDepartment of Emergency Medicine, Warren Alpert Medical School and School of Engineering, Brown University, Providence, RI, United States.
Miriam L HeynenCentre for Ocular Research and Education (CORE), School of Optometry and Vision Science, University of Waterloo, Waterloo, ON, Canada.
Gregory D JayDepartment of Emergency Medicine, Warren Alpert Medical School and School of Engineering, Brown University, Providence, RI, United States.
Barbara CafferyToronto Eye Care, Toronto, ON, Canada.
Lyndon JonesCentre for Ocular Research and Education (CORE), School of Optometry and Vision Science, University of Waterloo, Waterloo, ON, Canada.
Roman KrawetzMcCaig Institute, University of Calgary, Calgary, AB, Canada.
Tannin A SchmidtMcCaig Institute, University of Calgary, Calgary, AB, Canada.
Antoine DufourDepartments of Physiology and Pharmacology and Kinesiology, University of Calgary, Calgary, AB, Canada.
University of Calgary · CABrown University · USUniversity of Waterloo · CANorth Toronto Eye Care · CAUConn Health · US

Funding

Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)U01DE028891 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SHIBOSKI, CAROLINE HELENE · 2020 to 2024
$4.0M
INTERNATIONAL RESEARCH REGISTRY NETWORK FOR SJOGERNS SYNDROME-268032636N01DE032636 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GREENSPAN, JOHN · 2005 to 2006
–
NIDCR NIH HHS N01 DE032636NIDCR NIH HHS U01 DE028891
6 · The paper itself

Abstract

Sjogren's syndrome (SS) is characterized by dysfunctional mucous membranes and dysregulated moisture-secreting glands resulting in various symptoms, including dry mouth and dry eyes. Here, we wanted to profile and compare the tear and saliva proteomes of SS patients to healthy controls. Tear and saliva samples were collected and subjected to an isotopic dimethylation labeling shotgun proteomics workflow to identify alterations in protein levels. In tear samples, we identified 83 upregulated and 112 downregulated proteins. Pathway enrichment analysis of the changing proteins by Metascape identified leukocyte transendothelial migration, neutrophil degranulation, and post-translation protein phosphorylation in tears of SS patients. In healthy controls' tears, an enrichment for proteins related to glycolysis, amino acid metabolism and apoptotic signaling pathway were identified. In saliva, we identified 108 upregulated and 45 downregulated proteins. Altered pathways in SS patients' saliva included cornification, sensory perception to taste and neutrophil degranulation. In healthy controls' saliva, an enrichment for proteins related to JAK-STAT signaling after interleukin-12 stimulation, phagocytosis and glycolysis in senescence were identified. Dysregulated protease activity is implicated in the initiation of inflammation and immune cell recruitment in SS. We identified 20 proteases and protease inhibitors in tears and 18 in saliva which are differentially expressed between SS patients and healthy controls. Next, we quantified endogenous proteoglycan 4 (PRG4), a mucin-like glycoprotein, in tear wash and saliva samples via a bead-based immune assay. We identified decreased levels of PRG4 in SS patients' tear wash compared to normal samples. Conversely, in saliva, we found elevated levels of PRG4 concentration and visualized PRG4 expression in human parotid gland

Indexed as

lubricinPRG4proteaseprotease inhibitorproteomicssalivaSjogren's Syndrometears

Identifiers

PMID34950038
PMCPMC8689002
OpenAlexW4200438696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.